NGS, personalized medicine and early cancer detection are driving adoption, creating opportunities in liquid biopsy, precision oncology, drug development and recurring consumables.Dublin, Sept. (GLOBE ...

Pharmacogenetic testing can inform medication choice and adverse effect risk, while questions remain about implementation, data storage, and access in routine care.

For women who have been diagnosed with ovarian cancer, the questions that arise are those pertaining mostly to the ...

Integrating new AI screening tools for BRCA and HRD breast-cancer mutations into routine care could lead to earlier detection, more precise treatment, and lives saved. If they are aware of the threat, ...

Advanced multi-omics data analysis and biostatistical expertise to sharpen target and biomarker decisions across the platform PRINCETON, N.J., and NEW HAVEN, Conn., Sept. 14, 2026 (GLOBE NEWSWIRE) -- ...

There are different forms of embryo testing. Some tests screen for broader chromosomal abnormalities and cannot guarantee an ...

Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...

Insurance covers some genetic tests, such as BRCA tests for breast cancer, if you meet certain requirements. Find Cheap Health Insurance Quotes in Your Area But there are about 70,000 different ...

Advances in medicine, from genomics to biomarkers to artificial intelligence, have provided us with predictive tools that ...

Molecular geneticist Mitali Mukerji has spent her career exploring the intersection of genomics, traditional knowledge and ...